Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
External Expert Profile
Antonio Profico
Latest Publications
Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
